Stato dell’arte dei marcatori cardiaci in Italia: la III indagine del GdS MM SIMeL

No abstract is available for this paper.

• Publication year

  2014

• Venue

  La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine

• Publication date

  2014-10-10

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s13631-014-0069-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• High‐Sensitivity Troponin Assays: Evidence, Indications, and Reasonable Use

  2014cited by this paper
• Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk?

  2014cited by this paper
• Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE)

  2013cited by this paper
• Analytical characteristics of high-sensitivity cardiac troponin assays.

  2012cited by this paper
• B-type natriuretic peptide: from posttranslational processing to clinical measurement.

  2012influential reference
• Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.

  2012influential reference
• Novel Biomarkers for Risk Stratification and Identification of Life-threatening Cardiovascular Disease: Troponin and Beyond

  2012cited by this paper
• Mapping Turnaround Times (TAT) to a Generic Timeline: A Systematic Review of TAT Definitions in Clinical Domains

  2011cited by this paper
• The perils, pitfalls and opportunities of using high sensitivity cardiac troponin.

  2011cited by this paper
• Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction.

  2010cited by this paper
• An evidence-based algorithm for the use of B-type natriuretic testing in acute coronary syndromes.

  2010cited by this paper
• A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study

  2009cited by this paper
• Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms.

  2009cited by this paper
• Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions.

  2009cited by this paper
• Utilisation des marqueurs cardiaques et de la troponine en France

  2005cited by this paper
• Novel protein markers of acute coronary syndrome complications in low-risk outpatients: a systematic review of potential use in the emergency department.

  2005cited by this paper
• The redefinition of acute myocardial infarction.

  2004cited by this paper
• [Applicability of a new definition of myocardial infarction and the opinion of Spanish cardiologists].

  2003cited by this paper
• Surveys on the use of cardiac markers in the UK

  2003cited by this paper
• Aplicabilidad de la nueva definición de infarto de miocardio y opinión de los cardiólogos españoles

  2003cited by this paper
• Cardiac biomarkers and acute coronary syndromes--the Euro Heart Survey of Acute Coronary Syndromes Experience.

  2003cited by this paper
• Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers.

  2001cited by this paper
• International survey on the use of cardiac markers.

  2001cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Myocardial infarction redefined.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM).

  1999cited by this paper
• Enhetlig diagnostik av hjärtinfarkt - snabb utveckling på svenska sjukhus.

  1998cited by this paper
• [Uniform diagnosis of myocardial infarction. Rapid development at Swedish hospitals].

  1998cited by this paper

• Il problema dei falsi positivi e falsi negativi di troponina. Parte III: il ruolo dell'industria biomedica

  2019cites this paper
• La IV indagine del GdS MM SIPMeL: i marcatori miocardici di “necrosi” in Italia

  2018influential citation
• La troponina ad alta sensibilità in Italia

  2018cites this paper
• Point-of-care testing (POCT) per marcatori cardiaci in Italia. Dati e valutazioni dalla IV indagine del GdS MM SIPMeL

  2018cites this paper
• Stato dell’arte dei peptidi natriuretici cardiaci (PNC) in Italia. La IV indagine del GDS MM SIPMeL

  2018cites this paper
• How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction? The Italian Experience.

  2017cites this paper
• Raccomandazioni del Gruppo di Studio sui marcatori miocardici (GdS MM) di SIPMeL per l’implementazione di Point-of-care testing (POCT) per la determinazione della troponina (cTn)

  2016cites this paper